Related Experiment Video
Updated: Apr 30, 2026

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm
Published on: August 24, 2019
Melioidosis Aortic Aneurysms, 2019-2025: Incidence, Management and Outcomes From a Regional Tertiary Centre in North
Oh Sung Choy1,2, David Sun1,2, Vimalin Vedanayagam1
1Department of Vascular Surgery, Townsville University Hospital, Townsville, Queensland, Australia.
Introduction:
Melioidosis (organism: Burkholderia pseudomallei ) is an uncommon but serious cause of mycotic aortic aneurysms in endemic areas of North Queensland and Southeast Asia. This study describes the presentation, management, and outcomes of melioidosis-associated aortic aneurysms at a regional tertiary centre.
Methods:
A retrospective review of all open and endovascular aortic aneurysm repairs recorded in the Australasian Vascular Audit and in the institutional electronic database between 1 January 2019 and 15 May 2025 was performed. Patient demographics, comorbidities (including ischaemic heart disease, type 2 diabetes, hypertension, end-stage renal failure, and smoking status), aneurysm characteristics (location and maximum diameter), procedural details (repair type, American Society of Anesthesiologists (ASA) score and device selection) and outcomes at 30 days, 90 days and 12 months were collected.
Results:
Among 217 AAA repairs (17 open, 200 EVAR), six (2.8%) were mycotic and, of these, five (2.3%) yielded B. pseudomallei on culture. Four patients presented as emergency ruptures, while one with an ectatic aorta was referred electively by the infectious diseases team. Aneurysm diameters ranged from 30 mm to 60 mm, all involving the infrarenal aorta or aortoiliac segment. Two patients (40%) died-one from gastrointestinal complications within 30 days and another from an unrelated cardiac event at 12 months. The other three recovered without further aneurysm-related issues.
Conclusion:
Although rare, melioidosis aortic aneurysms in endemic regions almost invariably present as surgical emergencies and carry a high risk of both early and late mortality. These findings highlight the necessity of prompt imaging, targeted microbiological diagnosis, and rapid initiation of either endovascular or open repair together with appropriate antimicrobial therapy. Multicentre studies are needed to refine long-term management strategies and antibiotic protocols for this life-threatening infection.
Insights
Melioidosis-associated aortic aneurysms are rare but dangerous surgical emergencies in endemic areas. Prompt diagnosis and treatment are crucial for improving patient outcomes and reducing high mortality risks.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Medical Microbiology
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is an uncommon but severe cause of mycotic aortic aneurysms.
- Endemic regions include North Queensland and Southeast Asia, posing significant health risks.
Purpose of the Study:
- To describe the presentation, management, and outcomes of melioidosis-associated aortic aneurysms.
- To evaluate the effectiveness of current treatment strategies in a regional tertiary center.
Main Methods:
- Retrospective review of aortic aneurysm repairs (open and endovascular) from January 2019 to May 2025.
- Collection of patient demographics, comorbidities, aneurysm characteristics, procedural details, and short-term/long-term outcomes.
Main Results:
- Six out of 217 aortic aneurysm repairs (2.8%) were mycotic, with five yielding B. pseudomallei.
- Four patients presented with emergency ruptures; aneurysm diameters ranged from 30-60mm.
- Mortality rate was 40% (2/5 patients), with one early death and one late death from unrelated causes.
Conclusions:
- Melioidosis aortic aneurysms in endemic regions typically present as surgical emergencies with high mortality.
- Prompt imaging, microbiological diagnosis, and rapid surgical repair with antimicrobial therapy are essential.
- Multicenter studies are needed to optimize long-term management and antibiotic protocols.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care

